Cross-sectional and observational studies have demonstrated associations between serum 25(OH)D concentrations and cardiometabolic risk factors such as obesity, inflammation, glycemic control, insulin sensitivity, abnormal lipid profile, and high blood pressure (BP), but with inconsistent results [3–7]. The gene discussed is INS; the disease is Obesity.